Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
Li Duan(Chengde Medical University), Jiang Xia(Chinese University of Hong Kong), Kan Ouyang(Shenzhen Second People's Hospital), Yujie Liang(City University of Hong Kong), Yixin Xie(Shenzhen Second People's Hospital), Caining Wen(Shandong University of Technology), Xiao Xu(Shenzhen Second People's Hospital), Jianhong Wang(Xijing Hospital), Limei Xu(Xiamen University)
Cited by 78
Related Papers
Bioaugmentation and biostimulation of hydrocarbon degradation and the microbial community in a petroleum-contaminated soil
|International Biodeterioration & Biodegradation|2015|372
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
|Frontiers in Genetics|2021|360
Ultrafast Self‐Gelling and Wet Adhesive Powder for Acute Hemostasis and Wound Healing
|Advanced Functional Materials|2021|353
Antimicrobial peptides towards clinical application: Delivery and formulation
|Advanced Drug Delivery Reviews|2021|263
Exosome-mediated delivery of gene vectors for gene therapy
|Nanoscale|2020|236